Endocarditis due to Salmonella.
We present a case of endocarditis caused by Salmonella in a patient with newly diagnosed diabetes and preexisting rheumatic heart disease. Despite sterilization of the blood with a fluoroquinolone and a third-generation cephalosporin, the patient required surgical intervention.
Flannery
M T
MT
Department of Internal Medicine, University of South Florida College of Medicine, Tampa, USA.
Le
M
M
Altus
P
P
D000368:Aged; D000890:Anti-Infective Agents / Q000627:therapeutic use; D006328:Cardiac Catheterization; D002443:Ceftriaxone / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D017548:Echocardiography, Transesophageal; D004697:Endocarditis, Bacterial / Q000150:complications / Q000175:diagnosis* / Q000382:microbiology* / Q000628:therapy; D017809:Fatal Outcome; D005334:Fever / Q000382:microbiology; D006261:Headache / Q000382:microbiology; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D008297:Male; D009325:Nausea / Q000382:microbiology; D015242:Ofloxacin / Q000627:therapeutic use; D012214:Rheumatic Heart Disease / Q000150:complications; D012480:Salmonella Infections / Q000150:complications / Q000175:diagnosis* / Q000382:microbiology* / Q000628:therapy; D014839:Vomiting / Q000382:microbiology
D000890:Anti-Infective Agents; D002511:Cephalosporins; D002443:Ceftriaxone; D015242:Ofloxacin